Asian Phytoceuticals Public Company Limited - Depositary Receipt (Common Stock) - Laporan Laba Rugi (TTM)

Asian Phytoceuticals Public Company Limited - Depositary Receipt (Common Stock)
TH ˙ SET
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Asian Phytoceuticals Public Company Limited - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 239 248 234 235 228 223 231 230 238 250 278 289 303 293 264 249 227 211 204 200
Change (%) 3.63 -5.54 0.39 -3.08 -1.91 3.48 -0.28 3.38 5.08 11.01 3.86 4.89 -3.31 -9.72 -5.66 -9.08 -6.99 -3.23 -2.05
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 51 53 50 50 48 46 47 46 46 48 52 54 58 57 53 50 47 41 38 35
Change (%) 4.33 -6.10 0.86 -3.63 -4.13 1.93 -3.07 1.53 3.30 8.43 4.37 6.64 -1.05 -8.01 -4.49 -7.16 -12.28 -7.46 -7.53
% of Revenue 21.20 21.34 21.22 21.32 21.19 20.71 20.40 19.83 19.48 19.15 18.70 18.79 19.11 19.55 19.92 20.17 20.60 19.43 18.58 17.54
Gross Operating Profit 188 195 184 185 179 177 184 185 192 202 226 234 245 236 212 199 180 170 166 165
Change (%) 3.44 -5.38 0.26 -2.93 -1.31 3.89 0.44 3.84 5.51 11.62 3.74 4.49 -3.85 -10.14 -5.96 -9.57 -5.62 -2.21 -0.80
% of Revenue 78.80 78.66 78.78 78.68 78.81 79.29 79.60 80.17 80.52 80.85 81.30 81.21 80.89 80.45 80.08 79.83 79.40 80.57 81.42 82.46
SG&A 115 125 125 125 117 106 106 108 112 116 119 119 120 120 117 116 119 120 122 123
Change (%) 8.91 0.55 -0.48 -6.42 -8.99 -0.56 2.16 3.59 4.15 1.87 0.60 0.93 -0.64 -2.03 -0.93 2.79 0.54 1.84 0.44
% of Revenue 47.91 50.35 53.59 53.13 51.30 47.59 45.73 46.85 46.94 46.53 42.70 41.36 39.79 40.89 44.38 46.61 52.70 56.96 59.95 61.47
R&D
Change (%)
% of Revenue
OpEx 169 172 169 169 159 150 150 151 155 162 169 172 177 176 169 165 163 158 157 155
Change (%) 1.80 -1.62 -0.21 -5.79 -6.10 0.13 0.73 2.99 4.52 4.10 1.76 2.78 -0.51 -3.97 -2.03 -1.48 -3.25 -0.54 -1.50
% of Revenue 70.76 69.51 72.39 71.96 69.94 66.95 64.78 65.43 65.18 64.84 60.81 59.58 58.38 60.07 63.90 66.36 71.91 74.81 76.89 77.32
Operating Income 70 76 65 66 68 74 81 80 83 88 109 117 126 117 95 84 64 53 47 45
Change (%) 8.05 -14.46 1.97 3.90 7.85 10.27 -2.12 4.12 6.12 23.74 7.11 8.01 -7.25 -18.38 -12.09 -24.09 -16.58 -11.22 -3.89
% of Revenue 29.24 30.49 27.61 28.04 30.06 33.05 35.22 34.57 34.82 35.16 39.19 40.42 41.62 39.93 36.10 33.64 28.09 25.19 23.11 22.68
Interest Expense -0 -0 -1 -1 -1 -1 -1 -1 -1 -1 -0 -0 -0 -1 -1 -1 -2 -2 -2 -2
Change (%) 128.66 29.44 25.10 22.58 -8.63 -5.74 -9.84 -11.55 -12.84 -20.06 -18.69 -23.41 134.59 54.31 34.46 25.91 -7.80 2.74 0.82
% of Revenue -0.09 -0.19 -0.26 -0.33 -0.42 -0.39 -0.35 -0.32 -0.27 -0.23 -0.16 -0.13 -0.09 -0.23 -0.39 -0.55 -0.76 -0.76 -0.80 -0.83
Net Income 69 70 62 62 64 69 75 73 75 81 98 106 116 107 91 81 64 55 51 50
Change (%) 1.61 -11.37 -0.44 4.20 6.77 8.86 -2.40 2.70 7.95 21.26 8.08 9.24 -7.21 -14.95 -11.79 -21.16 -13.96 -7.21 -2.17
% of Revenue 28.81 28.25 26.50 26.29 28.26 30.76 32.36 31.67 31.46 32.32 35.30 36.74 38.26 36.72 34.59 32.35 28.05 25.95 24.88 24.85

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista